Title: Senior Toxicologist
Company: Bath & Body Works Direct, Inc.
Location: Edison, New Jersey, United States
Prathamesh Mahajan, Senior Toxicologist at Bath & Body Works Direct, Inc., has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in toxicology.
With over a decade of experience in toxicology and product safety, Mr. Mahajan has demonstrated exceptional leadership as a senior toxicologist and manager at Bath & Body Works Direct, Inc. since 2022. Prior to this role, he held positions of increasing responsibility, including senior toxicologist associate at Reckitt Benckiser Group PLC from 2019 to 2022, product safety manager at Living Proof from 2018 to 2019, and associate toxicologist at L’Oréal from 2015 to 2018. His journey began as a teaching assistant at St. John’s University from 2011 to 2014, during which he pursued dual Master of Science degrees in pharmacology and toxicology.
Building upon his academic foundation, Mr. Mahajan has garnered recognition for his contributions, receiving the Best Abstract Award from both the Society of Toxicology and the Mid-Atlantic Society of Toxicology. Beyond his professional duties, he actively engages in philanthropic endeavors at Bath & Body Works Direct, Inc., attributing his success to the mentorship he received and his openness to learning.
At L’Oréal, Mr. Mahajan played a pivotal role in advancing product safety standards by leading initiatives to minimize the reliance on human clinical trials for new products. Collaborating with colleagues and managers, he employed theoretical calculations and data analyses to effectively reduce the need for human studies, resulting in L’Oréal’s strategic shift away from routine clinical trials. Additionally, his expertise proved invaluable at Reckitt when the company faced a critical challenge of batch contamination. Through meticulous assessment and mitigation strategies, he prevented the disposal of approximately 20 batches, saving the company from potential losses totaling $5 million.
Looking ahead, Mr. Mahajan is determined to secure a leadership position and continue contributing to the growth and success of the industry. He finds fulfillment in promoting human health and safety and acknowledges the significant evolution of the field, particularly in reducing reliance on human clinical trials. His advice to aspiring professionals underscores the importance of continuous learning and technical proficiency in navigating the dynamic landscape of toxicology and product safety.
Contact Mr. Mahajan:
